Search results

Order by most recent / most popular / relevance

Results: 1-10 of 576

Putative class alleges pharma statements about new drug violated securities laws

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Federal Circuit addresses pleading standards for patent infringement claims

Shook Hardy & Bacon LLP
-
USA
-
May 2 2013

The Federal Circuit Court of Appeals has determined that a federal district court erred by relying on an incorrect pleading standard in dismissing

SCOTUS unanimously rules GM soybean patent infringed

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

The U.S. Supreme Court has determined that the "exhaustion doctrine" does not apply in the context of a patented genetically modified (GM) seed, and

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe

Silicon Valley companies welcome new USPTO outpost

Shook Hardy & Bacon LLP
-
USA
-
April 18 2013

The U.S. Patent and Trademark Office (USPTO) has begun hiring judges who will staff its Silicon Valley regional office and expects to eventually hire

Federal Circuit issues seven opinions on patentability of software innovations

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

The en banc Federal Circuit Court of Appeals has divided over whether method and computer-readable media claims and system claims are directed to

Universities abroad experiment with no-fee licensing to drive biotech partnerships

Shook Hardy & Bacon LLP
-
Australia, Canada, European Union, United Kingdom, USA
-
May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

New medical device regulations issued in Malaysia, effective July 1

Shook Hardy & Bacon LLP
-
Malaysia
-
February 8 2013

Malaysia's Minister of Health has approved medical device regulations under the Medical Device Act 2012 (Act 737); they were published in the Federal

Congress advances pharma supply chain and animal-drug user-fee laws

Shook Hardy & Bacon LLP
-
USA
-
May 16 2013

The House Energy and Commerce Subcommittee on Health has reportedly approved draft legislation that would change the existing lot-level

FDA argues to D.C. Circuit that stem cell treatment is a drug

Shook Hardy & Bacon LLP
-
USA
-
March 21 2013

Asserting that "FDA may lawfully regulate the creation of a new drug product even if it contains some of a patient's cells," the Food and Drug

next >

Search results

Putative class alleges pharma statements about new drug violated securities laws

Federal Circuit addresses pleading standards for patent infringement claims

SCOTUS unanimously rules GM soybean patent infringed

NASDAQ Biotechnology Index surpasses all-time high in 1Q13

Silicon Valley companies welcome new USPTO outpost

Federal Circuit issues seven opinions on patentability of software innovations

Universities abroad experiment with no-fee licensing to drive biotech partnerships

New medical device regulations issued in Malaysia, effective July 1

Congress advances pharma supply chain and animal-drug user-fee laws

FDA argues to D.C. Circuit that stem cell treatment is a drug

Current Search

Suggested Facets

Author

Jurisdiction

Workarea